Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SCARFONE, Giovanna")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 9 of 9

  • Page / 1
Export

Selection :

  • and

Response and toxicity to topotecan in sensitive ovarian cancer cases with small residual disease after first-line treatment with carboplatinum and paclitaxelBOLIS, Giorgio; SCARFONE, Giovanna; TATEO, Saverio et al.Gynecologic oncology (Print). 2001, Vol 80, Num 1, pp 13-15, issn 0090-8258Article

Clinical presentation of hydatidiform mole in northern Italy : has it changed in the last 20 years?MANGILI, Giorgia; GARAVAGLIA, Elisabetta; CAVORETTO, Paolo et al.American journal of obstetrics and gynecology. 2008, Vol 198, Num 3, pp 302-303, issn 0002-9378, 2 p.Article

Impact of Adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European organisation for research and treatment of cancer-adjuvant chemotherapy in ovarian neoplasm trialTRIMBOS, J. Baptist; VERGOTE, Ignace; GIURGEA, Livia et al.Journal of the National Cancer Institute. 2003, Vol 95, Num 2, pp 113-125, issn 0027-8874, 13 p.Article

Carboplatin alone vs carboplatin plus epidoxorubicin as second-line therapy for cisplatin- or carboplatin-sensitive ovarian cancerBOLIS, Giorgio; SCARFONE, Giovanna; GIARDINA, Giorgio et al.Gynecologic oncology (Print). 2001, Vol 81, Num 1, pp 3-9, issn 0090-8258Article

Weekly epirubicin in the treatment of gestational breast cancer (GBC)PECCATORI, Fedro A; AZIM, Hatem A; ROSSI, Piero et al.Breast cancer research and treatment. 2009, Vol 115, Num 3, pp 591-594, issn 0167-6806, 4 p.Article

A phase I/II study of topotecan in combination with carboplatin in recurrent epithelial ovarian cancerBOLIS, Giorgio; SCARFONE, Giovanna; SCIATTA, Cesarina et al.Gynecologic oncology (Print). 2001, Vol 83, Num 3, pp 477-480, issn 0090-8258Article

Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized studyBOLIS, Giorgio; SCARFONE, Giovanna; RASPAGLIESI, Francesco et al.European journal of cancer (1990). 2010, Vol 46, Num 16, pp 2905-2912, issn 0959-8049, 8 p.Article

Paclitaxel 175 or 225 mg per meters squared with carboplatin in advanced ovarian cancer: A randomized trialBOLIS, Giorgio; SCARFONE, Giovanna; VILLA, Antonella et al.Journal of clinical oncology. 2004, Vol 22, Num 4, pp 686-690, issn 0732-183X, 5 p.Article

p53 Gene status and response to platinum/paclitaxel-based chemotherapy in advanced ovarian carcinomaLAVARINO, Cinzia; PILOTTI, Silvana; MANGIONI, Costantino et al.Journal of clinical oncology. 2000, Vol 18, Num 23, pp 3936-3945, issn 0732-183XArticle

  • Page / 1